Evidence map›Paper›PMID 33470097›Full record

ArticleAnalytical chemistry2021

Multiplexed CuAAC Suzuki-Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling.

Jian Cao, Lisa M Boatner, Heta S Desai, Nikolas R Burton, Ernest Armenta, Neil J Chan, José O Castellón, Keriann M Backus

Open access · bronzeAbstract read
In one paragraph

Article in Analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Size-Dependent Target Engagement of Covalent Probes.Journal of medicinal chemistry · 2025
    Article
  10. Article
  11. Cholesterol binding to VCAM-1 promotes vascular inflammation.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jian CaoDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
Lisa M BoatnerDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.ORCID 0000-0003-0757-4982
Heta S DesaiDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
Nikolas R BurtonDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
Ernest ArmentaDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
Neil J ChanDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
José O CastellónDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.
Keriann M BackusDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, United States.ORCID 0000-0001-8541-1404
University of California, Los Angeles · US

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
Systems in Integrative BiologyT32GM008185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHOU, TOM · 1987 to 2022
$4.6M
Biotechnology Training in Biomedical Sciences and EngineeringT32GM067555 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GU, ZHEN · 2005 to 2019
$2.8M
NIGMS NIH HHS T32 GM007185NIGMS NIH HHS T32 GM008185NIGMS NIH HHS T32 GM067555
6 · The paper itself

Abstract

Mass-spectrometry-based chemoproteomics has enabled the rapid and proteome-wide discovery of functional and potentially 'druggable' hotspots in proteins. While numerous transformations are now available, chemoproteomic studies still rely overwhelmingly on copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) or 'click' chemistry. The absence of bio-orthogonal chemistries that are functionally equivalent and complementary to CuAAC for chemoproteomic applications has hindered the development of multiplexed chemoproteomic platforms capable of assaying multiple amino acid side chains in parallel. Here, we identify and optimize Suzuki-Miyaura cross-coupling conditions for activity-based protein profiling and mass-spectrometry-based chemoproteomics, including for target deconvolution and labeling site identification. Uniquely enabled by the observed orthogonality of palladium-catalyzed cross-coupling and CuAAC, we combine both reactions to achieve dual labeling. Multiplexed targeted deconvolution identified the protein targets of bifunctional cysteine- and lysine-reactive probes.

Indexed as

AlkynesAzidesCatalysisClick ChemistryCopperCycloaddition ReactionHEK293 CellsHumansMolecular StructureProteomicsAlkynesAzidesCopper

Identifiers

PMID33470097
PMCPMC8849040
OpenAlexW3125994417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.